| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DEBEL MARLENE | EVP & Chief Risk Officer | METLIFE, INC., 200 PARK AVENUE, NEW YORK | /s/ Taylor McInerney Jansen, Attorney-in-fact | 26 Feb 2026 | 0001770295 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MET | Common Stock | Award | +15,132 | +11% | 149,267 | 24 Feb 2026 | Direct | F1 | ||
| transaction | MET | Common Stock | Award | +14,870 | +10% | 164,137 | 24 Feb 2026 | Direct | F2 | ||
| transaction | MET | Common Stock | Tax liability | $423,712 | -5,624 | -3.4% | $75.34 | 158,513 | 24 Feb 2026 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. |
| F2 | Shares acquired from the determination of the performance factor for and payout of 2023-2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. |
| F3 | Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. |